A/Prof Elizabeth Christie
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
111 Scholarly works
12 Projects
HIGHLIGHTS
2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
DOI: 10.1038/s41467-026-71134-32026
Journal article
Endogenous replication stress creates a unique therapeutic window for ALC1 targeting.
DOI: 10.1038/s44319-026-00966-32026
Journal article
Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia.
DOI: 10.1158/1055-9965.EPI-25-18822024
Research grants (international)
Improving Ovarian Cancer Outcomes by Understanding and Targeting Acquired Resistance
2022
Research Grant
Investigating Treatment Response in Women’s Cancers
2019
Research Grant
Molecular and Spatial Characterization of Drug Resistance in Human Ovarian Cancer
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2026
Other
Supplementary Tables 1-16 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340411872026
Other
Supplementary Figure 12 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340412142026
Other
Supplementary Figure 5 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340412022026
Other
Supplementary Figure 10 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340412202026
Other
Supplementary Figure 11 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340412172026
Other
Supplementary Figure 3 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.340412082026
Other
Supplementary Figure 6 from Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia
DOI: 10.1158/1055-9965.34041199
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Driving Cancer Discoveries Through Integration of ‘Omics and Clinical Data